CHINA MEDICAL TECHNOLOGIES, INC SPN ADR
CMED
CMED was delisted on the 6th of February, 2012.
1 hedge funds and large institutions have $256 invested in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
CMED Hedge Fund Activity: Q4 2021 in Review
1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) for Q4 2021, worth a combined $256.
Buyers outnumbered sellers: 1 fund opened new CMED positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $256 of CHINA MEDICAL TECHNOLOGIES, INC SPN ADR stock for Q4 2021.
- 1 fund opened new CHINA MEDICAL TECHNOLOGIES, INC SPN ADR positions in Q4 2021 and 0 closed out, a net change of +1 holder.
Based on aggregated 13F filings for Q4 2021.